Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Skin Diseases, Papulosquamous”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00625326
What this trial is testing

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Deltanoid Pharmaceuticals 321
Early research (Phase 1)Study completedNCT03718884
What this trial is testing

Mirikizumab in Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Eli Lilly and Company 29
Not applicableStudy completedNCT04289233
What this trial is testing

Molecular & Cellular Characterisation of Oral Lichen Planus

Who this might be right for
Oral Lichen Planus
University of Birmingham 70
Testing effectiveness (Phase 2)Study completedNCT00778700
What this trial is testing

A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis

Who this might be right for
Psoriasis
Incyte Corporation 199
Large-scale testing (Phase 3)UnknownNCT06119672
What this trial is testing

Efficacy of Probiotic Capsules With Topical Clobetasol Propionate in OLP Treatment

Who this might be right for
Oral Lichen Planus
October 6 University 36
Not applicableStudy completedNCT06324695
What this trial is testing

Development and EValuation of an Online Intervention to Reduce Self-Stigma in People With Visible Chronic Skin disEases

Who this might be right for
PsoriasisAlopecia AreataHidradenitis Suppurativa+2 more
Universitätsklinikum Hamburg-Eppendorf 298
Not applicableStudy completedNCT02732145
What this trial is testing

Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis

Who this might be right for
Lichen SclerosusLichen PlanusLichen Simplex Chronicus+1 more
Ginekološka Poliklinika Dr. Vesna Harni 328
Testing effectiveness (Phase 2)Study completedNCT04991012
What this trial is testing

Evaluation of the Effectiveness of Photodynamic Therapy in the Treatment of Lesions of the Lichen Planus Type in the Oral Mucosa and Its Diagnostics With the Use of Autofluorescence, in Various Wavelength Ranges, in Combination With the Use of Texture Analysis and Fractal Dimension

Who this might be right for
Oral Lichen Planus
Wroclaw Medical University 30
Large-scale testing (Phase 3)Study completedNCT03090100
What this trial is testing

Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 1,048
Not applicableStudy completedNCT00550030
What this trial is testing

Etanercept Plus UVB-311nm Phototherapy in Psoriasis

Who this might be right for
Psoriasis
Medical University of Graz 6
Testing effectiveness (Phase 2)Study completedNCT03392168
What this trial is testing

Safety, Pharmacokinetics and Efficacy of ARQ-151 Cream in Adults With Mild to Moderate Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Arcutis Biotherapeutics, Inc. 91
Not applicableNot Yet RecruitingNCT07190391
What this trial is testing

Phase 4 Multicenter, Open-label Study on Efficacy and Safety of Apremilast in Moderate-to-severe Psoriasis

Who this might be right for
Psoriasis
Daewoong Pharmaceutical Co. LTD. 425
Testing effectiveness (Phase 2)Study completedNCT01490450
What this trial is testing

Psoriatic Arthritis Dose Ranging Study for BMS-945429 in Subjects Who Are Not Responding to NSAIDs or Non-biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) Therapy

Who this might be right for
Arthritis, Psoriatic
CSL Behring 165
Testing effectiveness (Phase 2)UnknownNCT03688971
What this trial is testing

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Who this might be right for
Seborrheic Dermatitis
Maruho Co., Ltd. 36
Post-approval studies (Phase 4)WithdrawnNCT00832364
What this trial is testing

Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis

Who this might be right for
Plaque Psoriasis
Stiefel, a GSK Company
Testing effectiveness (Phase 2)Study completedNCT05071664
What this trial is testing

Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis

Who this might be right for
Arthritis, Psoriatic
Janssen Research & Development, LLC 91
Testing effectiveness (Phase 2)Temporarily pausedNCT06723171
What this trial is testing

Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis

Who this might be right for
PsoriasisPlaque Type PsorisisPlaque Psoriasis
Io Therapeutics 20
Post-approval studies (Phase 4)Study completedNCT00794807
What this trial is testing

Safety and Tolerability of Repeat Courses of IM Alefacept

Who this might be right for
Chronic Plaque Psoriasis
Charite University, Berlin, Germany 20
Large-scale testing (Phase 3)Study completedNCT03123471
What this trial is testing

The Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp

Who this might be right for
Psoriasis
Amgen 303
Testing effectiveness (Phase 2)Study completedNCT01018134
What this trial is testing

Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study

Who this might be right for
Psoriasis
Sun Pharmaceutical Industries, Inc. 151
Next Page